ニューヨークにおけるアルツハイマー病の臨床試験
ニューヨーク内の拠点で、アルツハイマー病に関する37件の研究が参加者を募集しています。
ニューヨーク内の都市
- New York City21件の研究
- Queens8件の研究
- Newburgh5件の研究
- Staten Island4件の研究
- Albany4件の研究
- Syracuse4件の研究
- Rochester3件の研究
- Buffalo3件の研究
公式研究テキスト(英語)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, New York
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/30更新 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1656, New Windsor
- Local Institution - 2619, Staten Island
- Local Institution - 1658, Woodmere
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/28更新 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Alzheimer's Disease Research Center, Albany
被験者募集中第4相
50歳以上 · 全性別 · 2026/09/25更新 · NCT07633470A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Mid Hudson Medical Research PLLC, New Windsor
- SUNY Upstate Medical University, Syracuse
- Five Towns Neurology, PC, Woodmere
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/22更新 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Alzheimer's Disease Research Center, Albany
- Adams Clinic Harlem, New York
被験者募集中第2相
55歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Basil Clinical, Laurelton
- Weill Cornell Medical College, New York
- Adams Clinical Harlem, New York
- 他2件
被験者募集中第3相
50歳〜90歳 · 全性別 · 2026/09/21更新 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Neurological Associates Albany, Albany
- Dent Neurosciences Research Center, Inc, Amherst
- University at Buffalo - UBMD Neurology, Buffalo
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/09/17更新 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1610, Inwood
- Mid Hudson Medical Research, New Windsor
- Five Towns Neurology PC -Woodmere - 923 Broadway, Woodmere
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2647, Brooklyn
- Richmond Behavioral Associates, Staten Island
- Walnut Clinical Research, Valley Stream
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011745A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Basil Clinical, Laurelton
被験者募集中第3相
55歳〜80歳 · 全性別 · 2026/09/10更新 · NCT07717411Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University at Buffalo - UBMD Neurology, Buffalo
- The Feinstein Institute for Medical Research, Manhasset
- Mid Hudson Medical Research, New Windsor
- 他1件
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/01更新 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alzheimer Disease Research Center (ADRC) ( Site 1000), Albany
- Mid Hudson Medical Research ( Site 1050), New Windsor
- Basil Clinical ( Site 1065), Queens
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/08/26更新 · NCT07033494Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- The Research Foundation for State University of New York, Buffalo
被験者募集中
50歳以上 · 全性別 · 2026/08/24更新 · NCT07178210A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- NYU Langone Health, New York
- SUNY Upstate Medical University, Syracuse
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/08/20更新 · NCT06976216Early Age-Related Hearing Loss Investigation (EARHLI)
- Columbia University Medical Center, New York
被験者募集中
55歳〜75歳 · 全性別 · 2026/08/12更新 · NCT06174038The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- New York University, New York
- Mount Sinai, New York
被験者募集中
55歳〜85歳 · 全性別 · 2026/08/06更新 · NCT05988385Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
被験者募集中観察研究健康なボランティア歓迎
55歳〜90歳 · 全性別 · 2026/08/04更新 · NCT04239079Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
- 他1件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- New York University Medical Center, New York
被験者募集中第2/3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/27更新 · NCT05552157A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- New York University Medical Center, New York
被験者募集中第2/3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/27更新 · NCT06647498Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
- NYU Rory Meyers College of Nursing and VNS Health, New York
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/08更新 · NCT07182357Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
- Columbia University Irving Medical Center, New York
被験者募集中第2相健康なボランティア歓迎
50歳以上 · 全性別 · 2026/07/06更新 · NCT04576793Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
- Weill Cornell Medicine Brain Health Imaging Institute, New York
被験者募集中第2相
50歳以上 · 全性別 · 2026/05/22更新 · NCT07553338[18F]PI-2620 Phase 3 Histopathological Study
- Velocity Clinical Research, East Syracuse
- Ichor Research, Syracuse
被験者募集中第3相
50歳以上 · 全性別 · 2026/05/22更新 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS Only, Staten Island
被験者募集中観察研究
25歳〜55歳 · 全性別 · 2026/05/18更新 · NCT04165109Late Onset Alzheimer's Disease
- Columbia University Irving Medical Center, New York
被験者募集中観察研究健康なボランティア歓迎
55歳以上 · 全性別 · 2026/05/18更新 · NCT05010603Tele-Savvy for Latino Caregivers
- University of Rochester School of Nursing, Rochester
被験者募集中
18歳以上 · 全性別 · 2026/05/14更新 · NCT07290387Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
被験者募集中第4相
60歳以上 · 全性別 · 2026/05/06更新 · NCT05004987Genetic Studies of Early-onset Dementia
- Columbia University Irving Medical Center, New York
被験者募集中観察研究健康なボランティア歓迎
35歳以上 · 全性別 · 2026/04/29更新 · NCT04906863Tau Networks in Psychotic Alzheimer's Disease
- The Feinstein Institutes for Medical Research, Manhasset
被験者募集中観察研究健康なボランティア歓迎
65歳〜85歳 · 全性別 · 2026/04/08更新 · NCT05847192Dementia Caregivers' Link to Assistance and Resources
- VNS Health Home Care, New York
被験者募集中健康なボランティア歓迎
全年齢 · 全性別 · 2026/03/13更新 · NCT06860035Evaluating the Efficacy of the Pain Identification and Communication Toolkit
- Weill Cornell Medicine, New York
被験者募集中
21歳以上 · 全性別 · 2026/02/12更新 · NCT06168604Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Staten Island
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/02/02更新 · NCT07105709Daridorexant to Prevent Post-cardiotomy Delirium
- University of Rochester Medical Center, Rochester
被験者募集中第2相
60歳以上 · 全性別 · 2026/01/07更新 · NCT07217912Innate Immunity Stimulation Via TLR9 in Early AD
- NYU Langone Health, New York
被験者募集中第1相
60歳〜85歳 · 全性別 · 2026/01/07更新 · NCT05606341NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
被験者募集中観察研究
30 Days · 全性別 · 2025/03/03更新 · NCT06203106Triage Survey for Neurology Research Eligibility
- Berman Clinical, New York
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2023/10/27更新 · NCT06104852ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。